The internationalization of acupuncture and moxibustion in TCM

"At present, acupuncture and moxibustion of traditional Chinese medicine in the United States is still facing difficulties in integrating into mainstream medicine and being evaluated scientifically." Li Yongming, President of the American Society of acupuncture and moxibustion of traditional Chinese medicine, said in Chengdu on Tuesday that scientific evaluation research must be accelerated to realize internationalization of acupuncture and moxibustion of traditional Chinese medicine. From October 21 to 22, the Sixth International Conference on modernization of traditional Chinese medicine was held in Chengdu. At the sub chapter of "international cooperation and integration of science and technology in acupuncture and Moxibustion", the internationalization of traditional Chinese medicine and acupuncture has become a hot topic for experts at home and abroad. According to the report on global traditional medicine in 2019, among all the member countries of the World Health Organization, the number of countries applying acupuncture in traditional medicine system and technology category ranks first, reaching 113 countries. According to Li Yongming, who has been engaged in acupuncture treatment in the United States for more than 30 years, there are more than 39000 licensed acupuncturists in the United States, about 5000 Western doctors are qualified for acupuncture, 46 of the 50 states in the United States have issued independent laws and regulations related to acupuncture, and acupuncture has become more and more accepted in the United States.
But Americans only regard acupuncture as a kind of "fast food" treatment technology, and do not accept the traditional Chinese medicine theory and culture behind acupuncture. " Li Yongming said that traditional Chinese medicine culture still faces many difficulties in "going out" completely, "which requires the efforts of the people and conforms to the local history and culture." Liang Fanrong, a professor at Chengdu University of traditional Chinese medicine, also said that the internationalization of acupuncture and moxibustion in traditional Chinese medicine is facing the embarrassment of "only the supplement and replacement of mainstream medicine", which has not become mainstream medical therapy. "We must scientifically prove the effectiveness of acupuncture and moxibustion, and we must provide some high-quality scientific evaluation evidence." In order to solve this problem, jingxianghong, a researcher of Acupuncture Research Institute of Chinese Academy of traditional Chinese medicine, put forward "international big science plan of acupuncture and moxibustion medicine", which aims to give full play to the advantages of "functional regulation" of acupuncture and moxibustion medicine under the background of globalization development, reach a consensus of many countries, carry out multilateral scientific and technological cooperation, and clarify acupuncture and moxibustion through more standardized design and research. In order to show the clinical effect of acupuncture, we should establish a research paradigm that is in line with the clinical characteristics of acupuncture, and form a consensus on the methodology of acupuncture clinical research.
Looking for chemical products? Let suppliers reach out to you!
2026-07-14
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Let traditional Chinese medicine bring health and well-being to the people
-
Hunan Traditional Chinese Medicine Industry Welcomes Globalization
-
Does the Chinese patent medicine market never survive?
-
What should we do if the deficiency of support and expansion is not compensated?
-
Can TCM clinics make traditional Chinese medicine preparations?
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
NHU and Sinopec Advance Liquid Methionine Project
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
West Asia Tensions Squeeze Pharma Raw Materials
Recommend Reading
-
BASF Raises API and Excipient Prices
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
IPEC Updates Excipient Qualification Guidance
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
Domo Chemicals’ Triple Collapse: As Chinese Low-Cost Capacity Meets Europe’s Energy Wall, the First Crack Appears in the Continent’s Chemical Empire
-
New York’s Additive Ban Signals a Tougher Era for Food Formulation
-
Narrow Increase in China's Soda Ash Market in March
-
German Chemical Sentiment Hits a Three-Year Low: Supply Disruption Amplifies Pressure on European Manufacturing
-
Asia’s Plastics Chain Faces a Shock: Tight Naphtha Supply Drives Up Polymer Costs